Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

OptiCal Study -Optimizing Fecal Calprotectin Monitoring: a Clinical Study Comparing CalproLab Against PhiCal and Evaluating Its Association With the Gut Microbiome

NCT03051204 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.

NCT NCT03051204
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03051204 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
OptiCal Study -Optimizing Fecal Calprotectin Monitoring: a Clinical Study Comparing CalproLab Against PhiCal and Evaluating Its Association With the Gut Microbiome
Lead sponsor
University of California, Los Angeles
Phase
Observational
Overall status
Completed
Start date
February 28, 2017
Completion date
December 11, 2018
Enrollment
175 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

celiac disease, crohn disease, healthy, irritable bowel syndrome, ulcerative colitis